Evidence map›Paper›PMID 42477809›Full record

ArticleFluids and barriers of the CNS2026

Cerebral venous outflow disturbance exacerbates ischemic stroke via an endothelium-initiated inflammatory cascade: an integrated single-cell transcriptomic analysis.

Shiyan Qian, Ying Zhang, Guoqian Cui, Muzi Li, Lixiang Wang, Wenbo Guo, Xin Shao, Jie Liao, Qinghua Feng, Shengshuang Chen and 2 more

Abstract read
In one paragraph

Article in Fluids and barriers of the CNS, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Shiyan QianDepartment of Neurology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, 310006, China.
Ying ZhangPharmaceutical Informatics Institute, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China.
Guoqian CuiPharmaceutical Informatics Institute, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China.
Muzi LiPharmaceutical Informatics Institute, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China.
Lixiang WangDepartment of Neurology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, 310006, China.
Wenbo GuoPharmaceutical Informatics Institute, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China.
Xin ShaoPharmaceutical Informatics Institute, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China.
Jie LiaoPharmaceutical Informatics Institute, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China.
Qinghua FengDepartment of Neurology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, 310006, China.
Shengshuang ChenPharmaceutical Informatics Institute, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China. chenshsh@zju.edu.cn.
Xiao-Hui FanPharmaceutical Informatics Institute, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China. fanxh@zju.edu.cn.
Guoqing ZhengDepartment of Neurology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, 310006, China. gq_zheng@sohu.com.ORCID https://orcid.org/0000-0001-5286-5696

Funding

he National Natural Science Foundation of China 81973657he National Natural Science Foundation of China 82304883the Major Subject of the Zhejiang Provincial Natural Science Foundation of China D23H270001
6 · The paper itself

Abstract

backgroundUnfavorable cerebral venous outflow (VO) critically worsens ischemic stroke (IS) prognosis, yet the underlying cellular mechanisms driving this aggravation remain obscure. This study aimed to explore the impact of VO disturbance on ischemic brain injury.

methodsWe superimposed the left internal jugular vein occlusion (LIJVO) onto a rat model of ischemia/reperfusion (I/R). Key pathological indices were assessed and the transcriptomic landscape of the injury using the integrated single-cell and single-nucleus RNA sequencing approach, followed by immunofluorescence validation.

resultsSuperimposed LIJVO significantly exacerbated neurological deficits and infarction, precipitating malignant brain edema and blood-brain barrier breakdown (P < 0.05). The pathological expansion of pro-inflammatory Endothelial0 and Microglia1 subpopulations were identified. We traced these deteriorations to an endothelial-initiated inflammatory cascade: a specific Endothelial0 emerged to recruit leukocytes and trigger a feed-forward loop with hyper-reactive Microglia1. This crosstalk may drive a cytokine storm and tight junction collapse, ultimately leading to severe perivascular infiltration and accelerated neuronal injury.

conclusionCollectively, this study elucidates that unfavorable VO functions as a critical aggravator in IS via an endothelial-initiated inflammatory cascade. Targeting upstream endothelial activation represents a promising therapeutic strategy for the IS patients with compromised venous drainage.

Indexed as

Cerebral VeinsCerebrovascular CirculationEndothelium, VascularInflammationIschemic StrokeReperfusion InjuryAnimalsBlood-Brain BarrierDisease Models, AnimalGene Expression ProfilingJugular VeinsMaleRatsRats, Sprague-DawleySingle-Cell AnalysisSingle-Cell Gene Expression AnalysisCerebral venous drainageInflammationIschemic strokeSingle-cell transcriptomicsUnfavorable venous outflow

Identifiers

PMID42477809
PMCPMC13670818

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.